Genistein alters coagulation gene expression in ovariectomised rats treated with phytoestrogens

File Type:
PDFItem Type:
Journal ArticleDate:
2010Citation:
Kelly LA, O'Leary JJ, Seidlova-Wuttke D, Wuttke W, Norris LA, Genistein alters coagulation gene expression in ovariectomised rats treated with phytoestrogens, Thrombosis and Haemostasis, 104, 6, 2010, 1083-1289Download Item:
Abstract:
Recent data has shown that hormone therapy (HT) increases the risk of cardiovascular and thromboembolic disease, particularly in users of oral HT. Phytoestrogens are popular alternatives to oestrogen therapy; however, their effects on cardiovascular risk are unknown. We investigated the effect of the phytoestrogen, genistein on the expression of genes and proteins from the haemostatic system in the liver in an ovariectomised rat model. Fifty-nine virgin female Sprague-Dawley rats were fed with soy-free chow supplemented with 17? estradiol (E2) (daily uptake 0.19 or 0.75 mg/kg body weight), or genistein (daily uptake 6 or 60 mg/kg body weight), for three months and compared to soy-free control rats. Gene expression of prothrombin, factor VII, fibrinogen alpha and fibrinogen beta was increased with E2 and genistein compared to the soy-free control group (p<0.001). Genistein increased factor VII significantly more than E2 (p<0.005). Plasminogen mRNA was increased in both treatment groups compared to the soy-free control, with genistein expression significantly higher than E2 (p<0.001). Tissue plasminogen inhibitor (tPA), plasminogen activator inhibitor-1 (PAI-1) and C-reactive protein (CRP) expression were also increased in both groups relative the soy-free control. Results of protein analysis largely concurred with those of the mRNA. Oestrogen receptor ? (ER?) was undetected while oestrogen receptor ? (ER?) was detected in each sample group. Genistein can increase the expression of coagulation and fibrinolytic genes. This effect was similar and in some cases higher than 17? estradiol. These results suggest that genistein may not be neutral with respect to the haemostatic system.
Sponsor
Grant Number
Health Research Board (HRB)
Author's Homepage:
http://people.tcd.ie/lnorrishttp://people.tcd.ie/kellyl37
http://people.tcd.ie/olearyjj
Description:
PUBLISHEDBergamot Italy
Sponsor:
Health Research Board (HRB)Other Titles:
Thrombosis Research7th Internation Conference on Thrombosis & Hemostatis Issues in Cancer,
Contributors:
ISGOPublisher:
ElsevierType of material:
Journal ArticleSeries/Report no:
Thrombosis and Haemostasis104
6
Availability:
Full text availableSubject (TCD):
Cancer , Genes & SocietyMetadata
Show full item recordThe following license files are associated with this item: